Terence A. Ketter spends much of his time researching Bipolar disorder, Psychiatry, Mood, Internal medicine and Mania. His Bipolar disorder research incorporates elements of Randomized controlled trial, Mood disorders and Clinical psychology. His Psychiatry research is multidisciplinary, incorporating elements of Offspring, Affect and Pediatrics.
His study in Mood is interdisciplinary in nature, drawing from both Therapeutic effect, Polypharmacy, Depression and Peptide hormone. The study incorporates disciplines such as Endocrinology and Cardiology in addition to Internal medicine. His Mania research includes elements of Sleep disorder, Sleep deprivation and Lorazepam.
Bipolar disorder, Psychiatry, Internal medicine, Mood and Depression are his primary areas of study. His Bipolar disorder study integrates concerns from other disciplines, such as Tolerability and Clinical psychology. His study in Psychiatry focuses on Quetiapine, Olanzapine, Lamotrigine, Mood disorders and Comorbidity.
His studies examine the connections between Lamotrigine and genetics, as well as such issues in Carbamazepine, with regards to Anesthesia. His Internal medicine study incorporates themes from Young Mania Rating Scale, Placebo, Bipolar II disorder and Endocrinology. His Mood study combines topics in areas such as Anxiety disorder, Anxiety and Pediatrics.
His primary scientific interests are in Bipolar disorder, Psychiatry, Internal medicine, Mood and Depression. His Bipolar disorder research focuses on Mania in particular. Terence A. Ketter has researched Internal medicine in several fields, including Clinical Global Impression, Bipolar II disorder and Rating scale.
His work investigates the relationship between Mood and topics such as Body mass index that intersect with problems in White blood cell. In the field of Depression, his study on Irritability overlaps with subjects such as In patient. He has included themes like Antidepressant and Mood stabilizer in his Antipsychotic study.
The scientist’s investigation covers issues in Bipolar disorder, Psychiatry, Mood, Internal medicine and Quetiapine. His Bipolar disorder study results in a more complete grasp of Depression. His study focuses on the intersection of Psychiatry and fields such as Adverse effect with connections in the field of Lurasidone.
The concepts of his Mood study are interwoven with issues in Anxiety disorder and Sleep disorder, Sleep Wake Disorders. His study on Logistic regression and Discontinuation is often connected to Cariprazine as part of broader study in Internal medicine. His work carried out in the field of Quetiapine brings together such families of science as Randomized controlled trial and Mood stabilizer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mood disorders in the medically ill: scientific review and recommendations.
Dwight L. Evans;Dennis S. Charney;Dennis S. Charney;Lydia Lewis;Robert N. Golden.
Biological Psychiatry (2005)
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter.
Archives of General Psychiatry (2003)
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Gary S. Sachs;Andrew A. Nierenberg;Joseph R. Calabrese;Lauren B. Marangell.
The New England Journal of Medicine (2007)
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
Joseph R. Calabrese;Paul E. Keck;Wayne Macfadden;Margaret Minkwitz.
American Journal of Psychiatry (2005)
Brain activity during transient sadness and happiness in healthy women.
Mark S. George;Terence A. Ketter;Priti I. Parekh;Barry Horwitz.
American Journal of Psychiatry (1995)
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression.
Mark S. George;Eric M. Wassermann;Wendol A. Williams;Ann Callahan.
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Roy H. Perlis;Michael J. Ostacher;Jayendra K. Patel;Lauren B. Marangell.
American Journal of Psychiatry (2006)
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.
Mark A. Frye;Terence A. Ketter;Timothy A. Kimbrell;Timothy A. Kimbrell;Robert T. Dunn.
Journal of Clinical Psychopharmacology (2000)
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)
Gary S Sachs;Michael E Thase;Michael W Otto;Mark Bauer.
Biological Psychiatry (2003)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: